Predictive Oncology Inc. - Common Stock (NQ:POAI)

5.950 UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 11, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Predictive Oncology Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023

May 08, 2023

From Predictive Oncology Inc.

Via GlobeNewswire

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Appoints Seasoned Veteran as New Board Member

May 03, 2023

Via Investor Brand Network

Topics Artificial Intelligence

3 Undiscovered AI Stocks Set to Dominate the Market ↗

May 03, 2023

Here are three relatively undiscovered AI stocks that are flying below the radar of institutional investors but may produce outsized gains

Via InvestorPlace

Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors

May 02, 2023

From Predictive Oncology Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Monday ↗

April 24, 2023

On Monday, 147 stocks made new 52-week lows.

Via Benzinga

Nasdaq Edges Higher; Procter & Gamble Posts Upbeat Earnings ↗

April 21, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite edging higher on Friday. The Dow traded down 0.06% to 33,765.47 while the NASDAQ rose 0.02% to 12,062.18. The S&P 500, also...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

April 21, 2023

During Friday's session, 149 stocks hit new 52-week lows.

Via Benzinga

Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 21, 2023

Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.

Via Benzinga

Gold Down Over 1%; US Composite PMI Rises In April ↗

April 21, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 70 points on Friday. The Dow traded down 0.20% to 33,718.74 while the NASDAQ fell 0.33% to 12,019.40. The S&P 500,...

Via Benzinga

Why Predictive Oncology Stock Is Getting Hammered ↗

April 21, 2023

Predictive Oncology Inc (NASDAQ: POAI) shares are trading lower by 15.81% to $0.23 Friday morning after the company announced a reverse stock split. What Else? Per an SEC filing, the reverse stock...

Via Benzinga

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Reverse Stock Split Approved, Effective April 24

April 21, 2023

Via Investor Brand Network

Topics Artificial Intelligence

Why Sidus Space Shares Are Trading Lower By Around 24%; Here Are 20 Stocks Moving Premarket ↗

April 21, 2023

Gainers Wang & Lee Group, Inc. (NASDAQ: WLGS) jumped 266.1% to $11.35 in pre-market trading after dropping 38% on Thursday. WANG & LEE GROUP priced its initial public offering of 1,600,000 shares at a...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

April 21, 2023

It's time for a dive into the latest stock market happenings with the biggest pre-market stock movers worth watching on Friday!

Via InvestorPlace

Predictive Oncology Announces Reverse Stock Split

April 20, 2023

From Predictive Oncology Inc.

Via GlobeNewswire

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Special Meeting of Stockholders Rescheduled after ‘Lack of Required Quorum’

April 18, 2023

Via Investor Brand Network

Topics Artificial Intelligence

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 18, 2023

Via Benzinga

Predictive Oncology Adjourns Special Meeting of Stockholders

April 17, 2023

From Predictive Oncology Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 17, 2023

Via Benzinga

Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 17, 2023

Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 13, 2023

Via Benzinga

Why Alkaline Water Company Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket ↗

April 13, 2023

Gainers Auddia Inc. (NASDAQ: AUUD) jumped 115% to $1.14 in pre-market trading after gaining more than 10% on Wednesday.

Via Benzinga

Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 13, 2023

Gainers CXApp Inc. (NASDAQ: CXAI) jumped 105% to $3.28 after climbing over 20% on Wednesday.

Via Benzinga

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Names Oncology Translational Research Leader to Scientific Advisory Board

April 04, 2023

Via Investor Brand Network

Topics Artificial Intelligence

Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board

April 04, 2023

From Predictive Oncology Inc.

Via GlobeNewswire

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI), Integra Therapeutics Collaborate to Advance Gene Therapy

March 30, 2023

Via Investor Brand Network

Topics Artificial Intelligence

Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy

March 30, 2023

From Predictive Oncology Inc.

Via GlobeNewswire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.